A novel point-of-care whole blood coagulation assay to monitor emicizumab therapy in patients with hemophilia


Journal article


Michael A Suster, Debnath Maji, Lalitha V Nayak, Christina Jenkins, Susan Hunter, Alvin H Schmaier, Pedram Mohseni, Sanjay Ahuja
Blood, vol. 132, Elsevier, 2018, p. 2475

Cite

Cite

APA   Click to copy
Suster, M. A., Maji, D., Nayak, L. V., Jenkins, C., Hunter, S., Schmaier, A. H., … Ahuja, S. (2018). A novel point-of-care whole blood coagulation assay to monitor emicizumab therapy in patients with hemophilia. Blood, 132, 2475.


Chicago/Turabian   Click to copy
Suster, Michael A, Debnath Maji, Lalitha V Nayak, Christina Jenkins, Susan Hunter, Alvin H Schmaier, Pedram Mohseni, and Sanjay Ahuja. “A Novel Point-of-Care Whole Blood Coagulation Assay to Monitor Emicizumab Therapy in Patients with Hemophilia.” Blood 132 (2018): 2475.


MLA   Click to copy
Suster, Michael A., et al. “A Novel Point-of-Care Whole Blood Coagulation Assay to Monitor Emicizumab Therapy in Patients with Hemophilia.” Blood, vol. 132, Elsevier, 2018, p. 2475.


BibTeX   Click to copy

@article{suster2018a,
  title = {A novel point-of-care whole blood coagulation assay to monitor emicizumab therapy in patients with hemophilia},
  year = {2018},
  journal = {Blood},
  pages = {2475},
  publisher = {Elsevier},
  volume = {132},
  author = {Suster, Michael A and Maji, Debnath and Nayak, Lalitha V and Jenkins, Christina and Hunter, Susan and Schmaier, Alvin H and Mohseni, Pedram and Ahuja, Sanjay}
}